• MHRA recalls a further three batches of sartan-based products pharmaceutical-technology
    February 14, 2019
    The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has announced it has recalled three more batches of irbesartan as part of its continued investigation into potential N-nitrosodiethylamine (NDEA) contamination of .....
PharmaSources Customer Service